Ekso Bionics Holdings Inc

NASDAQ:EKSOUnited States

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.

Contact Information

Headquarters

101 GLACIER POINT, SUITE ASAN RAFAEL, CA, United States 94901

Phone

510-984-1761

Fax

702-866-2689

Executives

Chief Executive Officer, Director

Scott Davis

Chief Financial Officer, Corporate Secretary

Jerome Wong

Chief Operating Officer

Jason Jones

Director

Deborah Scher

Independent Director

Mary Cloyd